Literature DB >> 16553

Hypokalaemia in acute myeloid leukaemia.

M A Mir, B Brabin, O T Tang, M J Leyland, I W Delamore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 16553     DOI： 10.7326/0003-4819-82-1-54

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  14 in total

1.  Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals.

Authors:  Elena Ramírez; Tomás Rossignoli; Armando J Campos; Raúl Muñoz; Claudia Zegarra; Hoi Tong; Nicolás Medrano; Alberto M Borobia; Antonio J Carcas; Jesús Frías
Journal:  Eur J Clin Pharmacol       Date:  2012-05-31       Impact factor: 2.953

2.  Severe hypokalemia associated with pseudohypoxemia in acute nonlymphocytic leukemia.

Authors:  T A Depner; J A Magee
Journal:  West J Med       Date:  1988-09

3.  Exaggerated hypokalaemia in acute myeloid leukaemia.

Authors:  P C Adams; K W Woodhouse; M Adela; A Parnham
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-28

4.  Evidence for non-infiltrative cardiomyopathy in acute leukaemia and lymphoma. A clinical and echocardiographic study.

Authors:  M A Mir
Journal:  Br Heart J       Date:  1978-07

Review 5.  Potassium replacement: when is it necessary?

Authors:  A A Lawson
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

6.  Lysozyme and hypokalaemia.

Authors:  M A Mir; S C Lodha
Journal:  Postgrad Med J       Date:  1981-03       Impact factor: 2.401

7.  Hypokalaemia in leukaemia.

Authors:  A A Nanji; J Denegri
Journal:  Postgrad Med J       Date:  1981-08       Impact factor: 2.401

8.  Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.

Authors:  Judith E Karp; Amanda Blackford; B Douglas Smith; Katrina Alino; Amy Hatfield Seung; Javier Bolaños-Meade; Jacqueline M Greer; Hetty E Carraway; Steven D Gore; Richard J Jones; Mark J Levis; Michael A McDevitt; L Austin Doyle; John J Wright
Journal:  Leuk Res       Date:  2009-12-04       Impact factor: 3.156

9.  Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.

Authors:  B Lantz; J Adolfsson; B Lagerlöf; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 10.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.